Hims & Hers Health, Inc.

BMV:HIMS * Stock Report

Market Cap: Mex$114.9b

Hims & Hers Health Valuation

Is HIMS * undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of HIMS * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
Mex$1.15k
Fair Value
50.4% undervalued intrinsic discount
14
Number of Analysts

Below Fair Value: HIMS * (MX$570) is trading below our estimate of fair value (MX$1148.12)

Significantly Below Fair Value: HIMS * is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for HIMS *?

Key metric: As HIMS * is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for HIMS *. This is calculated by dividing HIMS *'s market cap by their current earnings.
What is HIMS *'s PE Ratio?
PE Ratio55.5x
EarningsUS$101.26m
Market CapUS$5.62b

Price to Earnings Ratio vs Peers

How does HIMS *'s PE Ratio compare to its peers?

The above table shows the PE ratio for HIMS * vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average77.7x
CRVL CorVel
69xn/aUS$5.6b
OPCH Option Care Health
19.7x4.4%US$4.1b
CHE Chemed
26.3x8.8%US$7.9b
PRVA Privia Health Group
195.9x34.2%US$2.4b
HIMS * Hims & Hers Health
55.5x15.7%Mex$5.6b

Price-To-Earnings vs Peers: HIMS * is good value based on its Price-To-Earnings Ratio (55.5x) compared to the peer average (77.7x).

Price to Earnings Ratio vs Industry

How does HIMS *'s PE Ratio compare vs other companies in the Global Healthcare Industry?

11 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No. of Companies73PE01632486480+
11 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: HIMS * is expensive based on its Price-To-Earnings Ratio (55.5x) compared to the Global Healthcare industry average (20.9x).

Price to Earnings Ratio vs Fair Ratio

What is HIMS *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

HIMS * PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio55.5x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate HIMS *'s Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst HIMS * forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentMex$570.00
Mex$533.29
-6.4%
21.0%Mex$775.70Mex$367.44n/a14
Jan ’26Mex$556.90
Mex$506.46
-9.1%
20.8%Mex$772.79Mex$366.06n/a13
Dec ’25Mex$655.00
Mex$485.52
-25.9%
15.3%Mex$643.75Mex$362.11n/a13
Nov ’25Mex$415.00
Mex$453.88
+9.4%
15.7%Mex$564.83Mex$322.76n/a12
Oct ’25Mex$368.00
Mex$421.20
+14.5%
18.1%Mex$576.23Mex$307.32n/a14
Sep ’25n/a
Mex$432.62
0%
17.9%Mex$584.24Mex$311.60n/a14
Aug ’25n/a
Mex$380.54
0%
19.6%Mex$467.72Mex$233.86n/a13
Jul ’25n/a
Mex$358.32
0%
24.2%Mex$478.70Mex$239.35n/a13
Jun ’25n/a
Mex$293.81
0%
22.6%Mex$440.88Mex$220.44n/a13
May ’25n/a
Mex$266.08
0%
23.8%Mex$394.37Mex$120.03n/a14
Apr ’25n/a
Mex$245.09
0%
20.4%Mex$300.36Mex$116.81n/a12
Mar ’25n/a
Mex$233.24
0%
19.0%Mex$290.13Mex$119.47n/a12
Feb ’25n/a
Mex$183.33
0%
23.1%Mex$253.13Mex$118.13n/a11
Jan ’25n/a
Mex$183.30
0%
24.2%Mex$259.61Mex$121.15Mex$556.9011
Dec ’24n/a
Mex$189.72
0%
24.5%Mex$264.73Mex$123.54Mex$655.0010
Nov ’24n/a
Mex$210.65
0%
22.7%Mex$308.27Mex$137.01Mex$415.0010
Oct ’24n/a
Mex$210.65
0%
22.7%Mex$308.27Mex$137.01Mex$368.0010
Sep ’24n/a
Mex$213.23
0%
21.8%Mex$308.17Mex$136.96n/a11
Aug ’24n/a
Mex$216.86
0%
17.0%Mex$300.27Mex$166.81n/a11
Jul ’24n/a
Mex$222.49
0%
17.0%Mex$308.07Mex$171.15n/a11
Jun ’24n/a
Mex$226.37
0%
17.2%Mex$317.88Mex$176.60n/a11
May ’24n/a
Mex$219.01
0%
21.7%Mex$324.82Mex$144.36n/a11
Apr ’24n/a
Mex$216.65
0%
18.4%Mex$271.95Mex$145.04n/a10
Mar ’24n/a
Mex$214.52
0%
18.7%Mex$271.54Mex$144.82n/a10
Feb ’24n/a
Mex$160.19
0%
26.2%Mex$228.84Mex$95.35n/a10
Jan ’24n/a
Mex$155.95
0%
25.5%Mex$232.48Mex$96.87n/a10
Analyst Price Target
Consensus Narrative from 14 Analysts
Mex$578.75
Fair Value
1.5% undervalued intrinsic discount
14
Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/09 09:02
End of Day Share Price 2025/01/08 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Hims & Hers Health, Inc. is covered by 22 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Vikram KesavabhotlaBaird
Allen LutzBofA Global Research
Michael ChernyBofA Global Research